Breaking News - The Fly

Open Search

DCPH

Deciphera

$

()

Deciphera sees NDA submission for Vimseltinib in 2Q24

DCPH

2/6/2024 - 07:08am

Deciphera sees NDA submission for Vimseltinib in 2Q24

DCPH

2/6/2024 - 07:08am

Deciphera reports Q4 EPS (54c), consensus (58c)

DCPH

2/6/2024 - 07:04am

Deciphera presents long-term follow-up results from INTRIGUE Phase 3 trial

DCPH

1/18/2024 - 11:23am

Deciphera, GENESIS Pharma enter distribution agreement for RIPRETINIB

DCPH

1/12/2024 - 06:37am

Deciphera publishes results from ctDNA analysis of INTRIGUE study

DCPH

1/5/2024 - 07:21am

Deciphera reinstated with a Neutral at JPMorgan

DCPH

11/20/2023 - 05:45am

Biotech Alert: Searches spiking for these stocks today

MGTX , DCPH , CHRS

…

11/1/2023 - 10:26am

Deciphera price target raised to $22 from $20 at Stifel

DCPH

10/31/2023 - 07:23am

Deciphera price target raised to $30 from $25 at H.C. Wainwright

DCPH

10/31/2023 - 06:12am

Deciphera upgraded to Buy from Hold at JonesResearch

DCPH

10/31/2023 - 05:05am

Piper upgrades Deciphera, sees vimseltinib and Qinlock poised for upside

DCPH

10/30/2023 - 11:04am

Deciphera upgraded to Overweight from Neutral at Piper Sandler

DCPH

10/30/2023 - 10:59am

Fly Intel: Pre-market Movers

SRC , MCD , XPO

…

10/30/2023 - 09:25am

Deciphera: MOTION study of vimseltinib met primary endpoint, key 2ndry endpoints

DCPH

10/30/2023 - 07:12am